Abstract:Abstract Background The carcinogenesis and progression of cervical cancer is a complex process in which numerous microRNAs are involved. The purpose of this study is to investigate the role of miR-125a-5p in progression of cervical cancer. Methods RT-qPCR was used to detect the expression of miR-125a-5p and GALNT7 in cervical cancer tissues and cell lines. Then, the miR-125a-5p mimic, miR-125a-5p inhibitor, GALNT7 siRNA, or/and pcDNA-GALNT7 were respectively transfected into HeLa and Caski cervical cancer cells, and Cell Counting kit-8 assay, Transwell assay and flow cytometry analysis were respectively used to observe cell proliferation, invasion and apoptosis. Subsequently, luciferase reporter gene assay was employed in confirming the target relationship between miR-125a-5p and GALNT7. MiR-125a-5p mimic or/and pcDNA-GALNT7 were transfected into the cervical cancer cells at the absence of epidermal growth factor (EGF) or not, and the pcDNA-GALNT7 was transfected into the cervical cancer cells at the absence of inhibitors of multiple kinases or not. Furthermore, the effect of miR-125a-5p on tumor growth was also studied using a xenograft model of nude mice. Results MiR-125a-5p was down-regulated in both cervical cancer tissues and cell lines and it inhibited cell proliferation and invasion of cervical cancer cells. MiR-125a-5p directly targeted and post-transcriptionally downregulated GALNT7 that was strongly upregulated in cervical cancer tissues and cell lines. Similar to the effect of miR-125a-5p mimic, silencing GALNT7 inhibited proliferation and invasion of cervical cancer cells. In addition, miR-125a-5p overexpression could counteract both GALNT7- and EGF-induced cell proliferation and invasion. GALNT7 promoted cell proliferation and invasion by activating the EGFR/PI3K/AKT kinase pathway, which could be abated by the inhibitors of the kinases. Moreover, the role of miR-125a-5p inhibited tumor formation in cervical cancer by suppressing the expression of GALNT7 in vivo. Conclusion In conclusion, miR-125a-5p suppressed cervical cancer progression by post-transcriptionally downregulating GALNT7 and inactivating the EGFR/PI3K/AKT pathway.

MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.

miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway

MiR-125b Promotes Cell Migration and Invasion by Targeting PPP1CA-Rb Signal Pathways in Gastric Cancer, Resulting in a Poor Prognosis

MiR-125 a suppresses ovarian cancer proliferation and motility by targeting HDAC 4

MicroRNA-125b expression in gastric adenocarcinoma and its effect on the proliferation of gastric cancer cells.

MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3

Ectopic Expression Of Mir-125a Inhibits The Proliferation And Metastasis Of Hepatocellular Carcinoma By Targeting Mmp11 And Vegf

MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway

MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways

MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT

MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.

Mir-125A-5p Suppresses Epithelial-Mesenchymal Transition Via GSK-3β/Snail Signaling Pathway in Breast Cancer Cells

Mir-125A-5p Inhibits the Migration of Breast Cancer Cells by Targeting GAB2

MicroRNA-125b Promotes Tumor Metastasis Through Targeting Tumor Protein 53-Induced Nuclear Protein 1 in Patients with Non-Small-cell Lung Cancer

MiR-125b Functions As a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma.

Progress on the Relationship Between Mir-125 Family and Tumorigenesis

Epidermal growth factor receptor-regulated miR-125a-5p--a metastatic inhibitor of lung cancer.

Roles and Mechanism of Mir-199A and Mir-125B in Tumor Angiogenesis

A germline mutation in the miR‑125a coding region reduces miR‑125a expression and is associated with human gastric cancer.

MicroRNA-125b Promotes Invasion and Metastasis of Gastric Cancer by Targeting STARD13 and NEU1

Mir-125B is Associated with Renal Cell Carcinoma Cell Migration, Invasion and Apoptosis